Trial intelligence / Profile preview

Oral 5-FU + Eniluracil vs IV 5-FU in Advanced Colorectal Cancer

NCT00003873Phase 3Completed

Sponsor
National Cancer Institute
Start
Apr 1999
Primary completion
Jul 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of eniluracil in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Apr 1999; status: completed.

02

Drugs

eniluracil
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00003873.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003873.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call